Syzygium aromaticum bud (clove) essential oil is a novel and safe aldose reductase inhibitor: in silico, in vitro, and in vivo evidence
Preclinical
Abstract
Clove (Syzygium aromaticum) bud essential oil showed antioxidant activity and acted as a novel, safe aldose reductase inhibitor in silico, in vitro and in vivo, supporting an antidiabetic role relevant to diabetic complications.
Referenced for these plants
How to cite
Irahal, I.N., Guenaou, I., Lahlou, F.A., Hmimid, F. and others (2022) 'Syzygium aromaticum bud (clove) essential oil is a novel and safe aldose reductase inhibitor: in silico, in vitro, and in vivo evidence', Hormones (Athens), 21(2), pp. 229-240. doi:10.1007/s42000-021-00347-6
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.